Assignee
UNIV HEIDELBERG
DE·22 granted patents·45 pending applications·93 citations·filing 1995–2025
Top patents by PatentIndex Score
67 records- 0190US10481095B2Methods and means for multispectral imagingUNIV HEIDELBERG·Filed 2015·Granted Nov 19, 2019·16 cites·17 claims
- 0287US5912411AMice transgenic for a tetracycline-inducible transcriptional activatorUNIV HEIDELBERG·Filed 1995·Granted Jun 15, 1999·64 cites·36 claims
- 0385US10684224B2Method and means for multispectral imagingUNIV HEIDELBERG·Filed 2015·Granted Jun 16, 2020·5 cites·20 claims
- 0479US2025127937A1Fap inhibitorUNIV HEIDELBERG·Filed 2024·Application pending·0 cites
- 0574US2025057993A1Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancersUNIV HEIDELBERG·Filed 2024·Application pending·0 cites
- 0671US2024299538A1Agent for use in the treatment of gliomaUNIV HEIDELBERG·Filed 2024·Application pending·0 cites
- 0771US2023112012A1Fap inhibitorUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 0870US2026000754A1Nanoparticles as carrier-system for adjuvants/antigensUNIV HEIDELBERG·Filed 2025·Application pending·0 cites
- 0969US11181532B2Delta-like ligand 1 for diagnosing severe infectionsUNIV HEIDELBERG·Filed 2018·Granted Nov 23, 2021·1 cites·16 claims
- 1067US2024025960A1Rage proteins for the treatment of fibrosis and dna damage mediated diseasesUNIV HEIDELBERG·Filed 2023·Application pending·0 cites
- 1165US2021038749A1Fap inhibitorUNIV HEIDELBERG·Filed 2019·Application pending·0 cites
- 1262US11841368B2Method and means for the rapid detection of HDV infectionsUNIV HEIDELBERG·Filed 2019·Granted Dec 12, 2023·0 cites·20 claims
- 1362US2026055441A1A pcr-elisa analogous antibody-free method for detecting a target nucleic acid in a sampleUNIV HEIDELBERG·Filed 2023·Application pending·0 cites
- 1460US2024200045A1Nuclease with improved targeting activityUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 1558US2025006368A1Sampling interval adjusted classification toolUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 1658US2026058010A1Method for classification of cancerUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 1757US2023151054A1Sulfur extrusion from disulfides by carbenesUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 1857US2023352149A1Single-cell morphology analysis for disease profiling and drug discoveryUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 1956US12448606B2Assay for FGF2 secretion and signalingUNIV HEIDELBERG·Filed 2021·Granted Oct 21, 2025·0 cites·8 claims
- 2056US2025206780A1Cyclic peptides and their use for the treatment of diseases associated with dicarbonyls like methylglyoxalUNIV HEIDELBERG·Filed 2023·Application pending·0 cites
- 2156US2025138206A1Sensor data processing module and method thereofUNIV HEIDELBERG·Filed 2023·Application pending·0 cites
- 2255US2019323926A1Use of a plastic film in the field of light microscopyUNIV HEIDELBERG·Filed 2019·Application pending·0 cites
- 2355US2024350250A1Endograft Device For Treating Ruptures In A Blood VesselUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 2454US2023183805A1Residual enzyme activity in metabolic diseaseUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 2553US11618773B2NFAT binding polynucleotidesUNIV HEIDELBERG·Filed 2019·Granted Apr 4, 2023·0 cites·15 claims
- 2653US2022127678A1Biomarker panel for diagnosis and prognosis of cancerUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 2753US2023211003A1Conjugate compounds for preventing and/or treating hbv and/or hdv infections, liver diseases andfor targeting ntcpUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 2853US2022008508A1Relaxin receptor 1 for use in treatment and prevention of heart failureUNIV HEIDELBERG·Filed 2019·Application pending·0 cites
- 2952US11123368B2Immunosuppressive blood cells and methods of producing the sameUNIV HEIDELBERG·Filed 2017·Granted Sep 21, 2021·0 cites·18 claims
- 3052US2022268770A13d-1d multidimensional cancer-on-a-chipUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 3149US2025052768A1In vitro methods for detecting dll1UNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 3248US2020140518A1Rage proteins for the treatment of fibrosis and dna damage mediated diseasesUNIV HEIDELBERG·Filed 2018·Application pending·0 cites
- 3347US11835405B2Force measuring disc and device for determining forces in the pico-newton to nano-newton rangeUNIV HEIDELBERG·Filed 2020·Granted Dec 5, 2023·0 cites·16 claims
- 3447US10842793B2Inhibitors of the unconventional secretion of fibroblast growth factor 2 (FGF2) by tumor cells and uses thereofUNIV HEIDELBERG·Filed 2017·Granted Nov 24, 2020·0 cites·9 claims
- 3547US10155041B2Bacterial phospholipase inhibitors as modulator of colonic bacterial floraUNIV HEIDELBERG·Filed 2015·Granted Dec 18, 2018·0 cites·13 claims
- 3647US2010160230A1Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune systemUNIV HEIDELBERG·Filed 2009·Application pending·0 cites
- 3747US2023107186A1Cobicistat for prevention and/or treatment of coronavirus infectionsUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 3847US2021363193A1Modified aav capsid polypeptides for treatment of muscular diseasesUNIV HEIDELBERG·Filed 2019·Application pending·0 cites
- 3947US2020368211A1Inhibition of gamma-glutamyltransferase and glutathione catabolism to enhance the efficacy of nf-kb signalling pathway inhibitorsUNIV HEIDELBERG·Filed 2018·Application pending·0 cites
- 4045US2017043026A1Bacterial phospholipase inhibitors as modulator of colonic bacterial floraUNIV HEIDELBERG·Filed 2016·Application pending·0 cites
- 4144US2022381770A1Artificial antigen presenting molecules and their usesUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 4244US2023105111A1System and Method for Teaching Minimally Invasive InterventionsUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 4343US12544485B2Method to prevent propagation of irregular electromechanical waves in the myocardium by creating lines of increased tissue conductivityUNIV HEIDELBERG·Filed 2019·Granted Feb 10, 2026·0 cites·13 claims
- 4443US11555063B2Norovirus antibodiesUNIV HEIDELBERG·Filed 2018·Granted Jan 17, 2023·0 cites·12 claims
- 4543US6384300B1Invertase inhibitorUNIV HEIDELBERG·Filed 1997·Granted May 7, 2002·7 cites·22 claims
- 4642US2022111013A1Compound decreasing the concentration of 2-hydroxy-glutarateUNIV HEIDELBERG·Filed 2020·Application pending·0 cites
- 4741US2021198328A1Modulated cas-inhibitorsUNIV HEIDELBERG·Filed 2018·Application pending·0 cites
- 4841US2023241233A1Oral pharmaceutical compositions comprising lipid conjugatesUNIV HEIDELBERG·Filed 2021·Application pending·0 cites
- 4940US10653796B2Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromoleculesUNIV HEIDELBERG·Filed 2016·Granted May 19, 2020·0 cites·13 claims
- 5040US2024358494A1Perivascular implantUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when UNIV HEIDELBERG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →